Gold prices bounce off 3-week lows; demand likely longer term
David Glockner, Executive Vice President of Compliance, Audit & Risk at Exelon Corp (NASDAQ:EXC), recently reported a sale of company stock valued at approximately $245,489. The transaction, dated February 3, involved the sale of 6,051 shares at a price of $40.57 per share, leaving Glockner with a total of 56,702 shares owned directly.
In addition to the sale, Glockner exercised options to acquire 40,171 shares of Exelon common stock. These transactions were executed at no cost under the company’s Long-Term Incentive Plan, which awards restricted stock units and performance shares based on company performance and vesting schedules. According to InvestingPro, Exelon maintains a "GOOD" overall financial health score and has consistently paid dividends for 54 consecutive years.
Following these transactions, Glockner also disposed of 10,253 shares to cover tax obligations, valued at $415,964, at the same $40.57 per share price.
These moves are part of routine financial strategies employed by company executives and are disclosed in accordance with SEC regulations to maintain transparency with investors.
In other recent news, Exelon Corporation has been the subject of favorable analyst adjustments. BMO Capital Markets recently increased its price target for Exelon to $46.00, maintaining an Outperform rating. The firm anticipates Exelon’s upcoming year-end earnings call will reveal an enhanced capital plan, focusing on additional transmission spending opportunities, which could extend the company’s rate base growth through 2028.
Simultaneously, Evercore ISI upgraded Exelon from an ’In Line’ rating to ’Outperform’, raising its price target to $44.00. The upgrade reflects an attractive risk/reward scenario, with a base case total return of 16%. Evercore ISI’s analyst, Durgesh Chopra, noted Exelon’s underperformance in 2024, but emphasized that the multi-year Illinois rate decision offers investment certainty through 2027.
These are recent developments, with both firms expecting Exelon’s upcoming fourth-quarter earnings release to provide crucial insights into the company’s 2025 EPS guidance range and a detailed four-year capital and financing plan for 2025-2028.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.